-
IPIT Study Links Chemotherapy Response to Heritable Factors
-
Located in
News
/
Current News
-
Discovery by Jin, Roth Could Lead to Better Schizophrenia Drugs
-
The research team found three first-in-class compounds that allow researchers to study which key signaling pathways are essential to the effectiveness and side effects of antipsychotics.
Located in
News
/
Current News
-
UNC Gets $100,000 Grant to Commercialize Huang, Kohn Inventions
-
Located in
News
/
Current News
-
Tropsha to Lead Research Efforts as Associate Dean, Lawrence to Chair Medicinal Chemistry Division
-
Alex Tropsha, PhD, (left) has been named as the School's new associate dean for research as of June 1. David Lawrence, PhD, will succeed him as chair of the Division of Medicinal Chemistry and Natural Products.
Located in
News
/
Current News
-
It's Time Formularies Paid Attention to Genetics, UNC Researchers Say
-
Located in
News
/
Current News
-
Study: Kids with Asthma Need More Help with Inhalers
-
A study led by Betsy Sleath, PhD, shows that health-care providers need to create better strategies to ensure that children with asthma use their inhalers correctly.
Located in
News
/
Current News
-
Lai Receives AACP New Faculty Award, NIAID Grant
-
An AACP New Faculty Award supports Sam Lai's efforts to improve the protective coatings of nanoparticles used to deliver drugs.
Located in
News
/
Current News
-
Study: More Patients Fill Prescriptions When Copays Are Lower
-
Located in
News
/
Current News
-
Lai's Gates Grant Will Put Viruses in Sticky Situation
-
A grant from the Bill & Melinda Gates Foundation will allow Sam Lai, PhD, to study how viruses penetrate mucous membranes, one of the body's first lines of defense against infection.
Located in
News
/
Current News
-
School Receives $6.6 Million to Finish Developing Radiation-Scrubbing Drug
-
Michael Jay, PhD, is the PI on an NIAID contract to create an easily administered form of DTPA, a drug that helps to remove radioactive elements from the body.
Located in
News
/
Current News
